SPY306.24+0.69 0.23%
DIA256.81+1.54 0.60%
IXIC9,516.68-35.37 -0.37%

Citigroup Maintains Buy on 10x Genomics, Raises Price Target to $100

Citigroup maintains 10x Genomics (NASDAQ:TXG) with a Buy and raises the price target from $90 to $100.

Benzinga · 05/12/2020 15:27

Citigroup maintains 10x Genomics (NASDAQ:TXG) with a Buy and raises the price target from $90 to $100.